Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate Leuprolide Acetate 45 mg 6-Month Formulation in Children With Central Precocious Puberty (CPP)

ClinicalTrials.gov ID: NCT03695237

Public ClinicalTrials.gov record NCT03695237. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 1:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Open-Label, Two-Part Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Leuprolide Acetate 45 mg 6-Month Depot Formulation in Children With Central Precocious Puberty (CPP)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of the study is to assess the safety and efficacy of a leuprolide acetate (LA) 45 mg 6-month depot formulation for the treatment of CPP in children who are either naïve to treatment with a gonadotropin-releasing hormone agonist (GnRHa) or who have been previously treated with a GnRHa.

Study identification

NCT ID
NCT03695237
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
45 participants

Conditions and interventions

Eligibility (public fields only)

Age range
2 Years to 11 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 24, 2018 (Actual)
Primary completion
May 6, 2021 (Actual)
Completion
Nov 29, 2023 (Actual)
Last update posted
May 29, 2024

2018 – 2023

United States locations

U.S. sites
17
U.S. states
13
U.S. cities
17
Facility City State ZIP Site status
Pediatric Endocrinology Associates /ID# 200629 Long Beach California 90806-1651 —
Rady Children's Hospital San Diego /ID# 202491 San Diego California 92123 —
Children's Hospital Colorado /ID# 201645 Aurora Colorado 80045 —
Pediatric Endocrine Associates /ID# 201089 Greenwood Village Colorado 80111 —
Nemours Children's Health System /ID# 201331 Jacksonville Florida 32207 —
Arnold Palmer Hospital /ID# 201624 Orlando Florida 32806 —
Van Meter Pediatric Endocrinology /ID# 201688 Atlanta Georgia 30318-2508 —
Rocky Mountain Diabetes and Osteoporosis Center /ID# 209878 Idaho Falls Idaho 83404-7596 —
Indiana University /ID# 200526 Indianapolis Indiana 46202 —
Pediatric Endocrine Associates /ID# 202396 Boston Massachusetts 02114 —
University of Minnesota /ID# 200508 Minneapolis Minnesota 55455-1450 —
Children's Mercy Hospital/ID# 200221 Kansas City Missouri 64111 —
University of Oklahoma /ID# 200659 Tulsa Oklahoma 74135-2527 —
Penn State Hershey Medical Ctr /ID# 200287 Hershey Pennsylvania 17033-2360 —
Children's Hospital of Philadelphia - Main /ID# 203846 Philadelphia Pennsylvania 19104-4319 —
Cook Children's Med. Center /ID# 212937 Fort Worth Texas 76104 —
Multicare Institute for Research and Innovation /ID# 202188 Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03695237, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 29, 2024 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03695237 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →